Yukiya Yamaguchi

Title: Yukiya Yamaguchi: Innovator in Pharmaceutical Composition

Introduction

Yukiya Yamaguchi is a notable inventor based in Konan, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on dihydropyridine compounds. His research has led to advancements in drug formulations that enhance bioavailability and absorption.

Latest Patents

Yamaguchi holds 1 patent for a pharmaceutical composition that includes a 1:1 solvate of a specific dihydropyridine compound. This composition, which features 5-(5,5-dimethyl-1,3,2-dioxaphosphorinane-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridine carboxylic acid 2-(phenylmethyl)amino) ethyl ester P-oxide hydrochloride-thanol (NZ-105) and hydroxypropylmethylcellulose acetate succinate, can be easily prepared into various forms such as tablets, capsules, granules, and powders. The formulation is designed to provide a high blood concentration of the active component NZ-105, ensuring enhanced total drug absorption.

Career Highlights

Throughout his career, Yukiya Yamaguchi has worked with prominent companies in the pharmaceutical industry. He has been associated with Zeria Pharmaceutical Co., Ltd. and Nissan Chemical Industries Limited, where he has contributed to the development of innovative drug formulations.

Collaborations

Yamaguchi has collaborated with esteemed colleagues, including Masaharu Miyajima and Takao Tsunematsu, to further advance his research and development efforts in pharmaceuticals.

Conclusion

Yukiya Yamaguchi's contributions to pharmaceutical compositions demonstrate his commitment to enhancing drug efficacy and bioavailability. His innovative work continues to impact the field positively.